Daniel Preece, DPM
Foot & Ankle Surgery · Salt Lake City, UTNPI 1639306889
Payments from drug & device makers
What this record shows
This record is dominated by grants: $6,000 of the $7,055 with a category attached, or 85.0%. Paragon 28, Inc. accounts for 86.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $6,382 and has fallen 97.8% since, to $138 in 2025.
Across 42 payments — averaging $167.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$6K
- Treace Medical Concepts, Inc.$147
- Boston Scientific$126
- Abbott$122
- Stryker$96
- Nevro Corp.$86
- plus $397 from 9 others
What the payments were for
- Grants$6,00085%
- Food & beverage$1,05515%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 5 | $6,081 |
| Treace Medical Concepts, Inc. | 4 | $147 |
| Boston Scientific | 2 | $126 |
| Abbott | 1 | $122 |
| Stryker(2 entities) | 4 | $96 |
| Nevro Corp. | 1 | $86 |
| Mimedx Group, Inc. | 5 | $83 |
| Smith+Nephew | 5 | $76 |
| Organogenesis Inc. | 5 | $70 |
| Amgen | 2 | $56 |
| KCI USA, Inc. | 2 | $33 |
| Medline Industries LP | 2 | $27 |
| Merck | 2 | $25 |
| Solventum Corporation | 1 | $15 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,055 in reported general payments places this provider in the 70th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 100 | $2,369 |
| Pregabalin | 42 | $1,274 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $355 |
| Cephalexin | 34 | $351 |
| Allopurinol | 32 | $324 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $198 |
| Doxycycline Hyclate | 18 | $176 |
| Levofloxacin | 12 | $135 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Salt Lake City
- Gregory AndersonSalt Lake City$1.6M
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- David SeegmillerSalt Lake City$120K
- Grant SunSalt Lake City$11K
- Amanda KhourySalt Lake City$10K
- Callie MorlockSalt Lake City$9K
- Jordan ButterfieldSalt Lake City$7K
- Christopher FunkSalt Lake City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.